These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 21835017)

  • 21. Influenza B mutant viruses with truncated NS1 proteins grow efficiently in Vero cells and are immunogenic in mice.
    Wressnigg N; Shurygina AP; Wolff T; Redlberger-Fritz M; Popow-Kraupp T; Muster T; Egorov A; Kittel C
    J Gen Virol; 2009 Feb; 90(Pt 2):366-374. PubMed ID: 19141445
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NS-based live attenuated H1N1 pandemic vaccines protect mice and ferrets.
    Zhou B; Li Y; Belser JA; Pearce MB; Schmolke M; Subba AX; Shi Z; Zaki SR; Blau DM; García-Sastre A; Tumpey TM; Wentworth DE
    Vaccine; 2010 Nov; 28(50):8015-25. PubMed ID: 20934458
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Establishment of a mink enteritis vaccine production process in stirred-tank reactor and Wave Bioreactor microcarrier culture in 1-10 L scale.
    Hundt B; Best C; Schlawin N; Kassner H; Genzel Y; Reichl U
    Vaccine; 2007 May; 25(20):3987-95. PubMed ID: 17391818
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High vero cell density and rabies virus proliferation on fibracel disks versus cytodex-1 in spinner flask.
    Hassanzadeh SM; Zavareh A; Shokrgozar MA; Ramezani A; Fayaz A
    Pak J Biol Sci; 2011 Apr; 14(7):441-8. PubMed ID: 21902056
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Downstream processing of Vero cell-derived human influenza A virus (H1N1) grown in serum-free medium.
    He C; Yang Z; Tong K
    J Chromatogr A; 2011 Aug; 1218(31):5279-85. PubMed ID: 21726872
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Production of cell culture (MDCK) derived live attenuated influenza vaccine (LAIV) in a fully disposable platform process.
    George M; Farooq M; Dang T; Cortes B; Liu J; Maranga L
    Biotechnol Bioeng; 2010 Aug; 106(6):906-17. PubMed ID: 20589670
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel type of influenza vaccine: safety and immunogenicity of replication-deficient influenza virus created by deletion of the interferon antagonist NS1.
    Wacheck V; Egorov A; Groiss F; Pfeiffer A; Fuereder T; Hoeflmayer D; Kundi M; Popow-Kraupp T; Redlberger-Fritz M; Mueller CA; Cinatl J; Michaelis M; Geiler J; Bergmann M; Romanova J; Roethl E; Morokutti A; Wolschek M; Ferko B; Seipelt J; Dick-Gudenus R; Muster T
    J Infect Dis; 2010 Feb; 201(3):354-62. PubMed ID: 20039806
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of an HSV-1 production process involving serum-reduced culturing and bead-to-bead transfer.
    Wang H; Hu X; Zhang M; Yang L; Xu Y; Gu X; Jiang J; Hu W
    Appl Microbiol Biotechnol; 2024 Jun; 108(1):383. PubMed ID: 38896301
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High cell density perfusion process for high yield of influenza A virus production using MDCK suspension cells.
    Wu Y; Bissinger T; Genzel Y; Liu X; Reichl U; Tan WS
    Appl Microbiol Biotechnol; 2021 Feb; 105(4):1421-1434. PubMed ID: 33515287
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of MDCK cells for production of live attenuated influenza vaccine.
    Liu J; Shi X; Schwartz R; Kemble G
    Vaccine; 2009 Oct; 27(46):6460-3. PubMed ID: 19559113
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rearrangement of Influenza Virus Spliced Segments for the Development of Live-Attenuated Vaccines.
    Nogales A; DeDiego ML; Topham DJ; Martínez-Sobrido L
    J Virol; 2016 Jul; 90(14):6291-6302. PubMed ID: 27122587
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of egg and high yielding MDCK cell-derived live attenuated influenza virus for commercial production of trivalent influenza vaccine: in vitro cell susceptibility and influenza virus replication kinetics in permissive and semi-permissive cells.
    Hussain AI; Cordeiro M; Sevilla E; Liu J
    Vaccine; 2010 May; 28(22):3848-55. PubMed ID: 20307595
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Wave microcarrier cultivation of MDCK cells for influenza virus production in serum containing and serum-free media.
    Genzel Y; Olmer RM; Schäfer B; Reichl U
    Vaccine; 2006 Aug; 24(35-36):6074-87. PubMed ID: 16781022
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Vero-cell-adapted vaccine donor strain of influenza A virus generated by serial passages.
    Hu W; Zhang H; Han Q; Li L; Chen Y; Xia N; Chen Z; Shu Y; Xu K; Sun B
    Vaccine; 2015 Jan; 33(2):374-81. PubMed ID: 25448099
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increasing Vero viable cell densities for yellow fever virus production in stirred-tank bioreactors using serum-free medium.
    Mattos DA; Silva MV; Gaspar LP; Castilho LR
    Vaccine; 2015 Aug; 33(35):4288-91. PubMed ID: 25930117
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel animal-component-free medium for rabies virus production in Vero cells grown on Cytodex 1 microcarriers in a stirred bioreactor.
    Rourou S; van der Ark A; Majoul S; Trabelsi K; van der Velden T; Kallel H
    Appl Microbiol Biotechnol; 2009 Nov; 85(1):53-63. PubMed ID: 19521697
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interplay of PA-X and NS1 Proteins in Replication and Pathogenesis of a Temperature-Sensitive 2009 Pandemic H1N1 Influenza A Virus.
    Nogales A; Rodriguez L; DeDiego ML; Topham DJ; Martínez-Sobrido L
    J Virol; 2017 Sep; 91(17):. PubMed ID: 28637750
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Selected problems of manufacturing influenza vaccines].
    Augustynowicz E
    Przegl Epidemiol; 2010; 64(3):373-80. PubMed ID: 20976949
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of a mammalian cell (Vero) derived candidate influenza virus vaccine.
    Kistner O; Barrett PN; Mundt W; Reiter M; Schober-Bendixen S; Dorner F
    Vaccine; 1998; 16(9-10):960-8. PubMed ID: 9682344
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Development of new nutrient medium for MDCK and Vero cells based on soy hydrolysate obtained using bromeline and assessment of growth characteristics of influenza virus vaccine strains cultivated on them].
    Mazurkova NA; Troshkova ; Shishkina LN; Stavskiĭ EA; Drozdov IG
    Zh Mikrobiol Epidemiol Immunobiol; 2011; (1):86-90. PubMed ID: 21449080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.